We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesSolventum Corp.

Solventum Corp.

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
88.42 USD -0.20 ( 0.23%)
Last update at 2026-11-12T15:43:00Z
VOLUME
58085
Market Cap
15330.35M
P/E
10.98

Momentum Score

…

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
87.50
Low
89.28
High
52 Week Price Range
62.38
Low
94.16
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public disclosures for Solventum Corp. (NYSE: SOLV.US) are limited, so its specific products, industry and operations are not clearly described in available filings. Its long-term growth drivers and competitive position are unclear, and any potential upside may depend on future disclosure of strategy and execution.

The principal investment risk is the significant information gap and transparency risk, which increases uncertainty about financial condition, execution capability and regulatory or financing exposure.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
88.62
Dividend Yield
-
Revenue TTM
8310.00M
Revenue Per Share
47.79
Gross Profit TTM
4552.00M
Debt / Equity
1.00
ROE
33.96%
Net Debt
4157.00M
ROCE
18.46%
Diluted EPS TTM
8.20

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 1713.00M 605.00M 1667.00M 1692.00M 1882.00M
Net income 1556.00M 479.00M 1346.00M 1343.00M 1460.00M
Selling general administrative 3080.00M 2782.00M 2321.00M 2235.00M 2278.00M
Gross profit 4451.00M 4593.00M 4693.00M 4695.00M 4923.00M
Reconciled depreciation 489.00M 555.00M 561.00M 578.00M 597.00M
Ebit 2060.00M 972.00M 1667.00M 1692.00M 1882.00M
Ebitda 2549.00M 1527.00M 2228.00M 2270.00M 2479.00M
Depreciation and amortization 489.00M 555.00M 561.00M 578.00M 597.00M
Operating income 2181.00M 1036.00M 1692.00M 1693.00M 1879.00M
Other operating expenses 6144.00M 7218.00M 6505.00M 6437.00M 6292.00M
Interest expense 347.00M 367.00M 0.00M 0.00M -
Tax provision 157.00M 127.00M 218.00M 349.00M 422.00M
Net interest income -347.00M -367.00M 0.00M 0.00M -
Income tax expense 157.00M 127.00M 321.00M 349.00M 422.00M
Total revenue 8325.00M 8254.00M 8197.00M 8130.00M 8171.00M
Total operating expenses 2270.00M 3557.00M 3001.00M 3002.00M 3044.00M
Cost of revenue 3874.00M 3661.00M 3504.00M 3435.00M 3248.00M
Total other income expense net -468.00M -431.00M -25.00M -1.00M 3.00M
Net income from continuing ops 1556.00M 478.00M 692.00M 1343.00M 1460.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 14294.00M 14457.00M 13943.00M 13594.00M 14075.00M
Intangible assets 2592.00M 2544.00M 2902.00M 3252.00M 3661.00M
Other current assets 881.00M 293.00M 155.00M 126.00M 108.00M
Total liab 9245.00M 11498.00M 2277.00M 1852.00M 2016.00M
Total stockholder equity 5049.00M 2959.00M 11666.00M 11742.00M 12059.00M
Other current liab 1828.00M 1191.00M 571.00M 377.00M 1057.00M
Common stock 2.00M 2.00M 2.00M 12239.00M 12259.00M
Capital stock 2.00M 2.00M 2.00M - -
Retained earnings 1797.00M 242.00M 0.00M - -
Good will 5704.00M 6377.00M 6535.00M 6434.00M 6666.00M
Cash 878.00M 762.00M 194.00M 61.00M 91.00M
Total current liabilities 3136.00M 2703.00M 1728.00M 1311.00M 1406.00M
Current deferred revenue 621.00M 572.00M 574.00M 559.00M 574.00M
Net debt 4157.00M 7248.00M 8109.00M 34.00M 21.00M
Short term debt - 200.00M 29.00M 27.00M 29.00M
Short long term debt - 200.00M - - -
Short long term debt total 5035.00M 8010.00M 8303.00M 95.00M 112.00M
Other stockholder equity 3875.00M 3771.00M 12003.00M 12239.00M 12259.00M
Total current assets 3859.00M 3249.00M 2519.00M 2231.00M 2189.00M
Short term investments - - 406.00M - -
Net receivables 1034.00M 1229.00M 1313.00M 1171.00M 1177.00M
Long term debt 5035.00M 7810.00M 8303.00M - -
Inventory 1066.00M 965.00M 857.00M 873.00M 813.00M
Accounts payable 687.00M 618.00M 477.00M 348.00M 320.00M
Accumulated other comprehensive income -625.00M -1056.00M -337.00M -497.00M -200.00M
Non currrent assets other 813.00M 665.00M 530.00M 358.00M 253.00M
Non current assets total 10435.00M 11208.00M 11424.00M 11363.00M 11886.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -380.00M -230.00M -253.00M -278.00M
Total cashflows from investing activities 2797.00M -380.00M -230.00M -253.00M -278.00M
Net borrowings -3070.00M 8003.00M 0.00M 0.00M -
Total cash from financing activities -3057.00M -240.00M -1552.00M -1460.00M -1960.00M
Net income 1556.00M 479.00M 1346.00M 1343.00M 1460.00M
Change in cash 116.00M 568.00M 133.00M -30.00M -33.00M
Begin period cash flow 762.00M 194.00M 61.00M 91.00M 124.00M
End period cash flow 878.00M 762.00M 194.00M 61.00M 91.00M
Total cash from operating activities 369.00M 1185.00M 1915.00M 1679.00M 2202.00M
Depreciation 489.00M 555.00M 561.00M 578.00M 597.00M
Other cashflows from investing activities 3872.00M - - -2.00M -1.00M
Change to inventory -139.00M -132.00M 23.00M -82.00M -136.00M
Change to account receivables 78.00M 276.00M -129.00M -32.00M -1.00M
Other cashflows from financing activities 13.00M -8243.00M -1552.00M -1460.00M -1960.00M
Capital expenditures 379.00M 380.00M 290.00M 251.00M 277.00M
Change in working capital -119.00M 160.00M 126.00M -202.00M 67.00M
Stock based compensation 161.00M 112.00M 39.00M 37.00M 38.00M
Other non cash items -1598.00M 34.00M -15.00M 64.00M 74.00M
Free cash flow -10.00M 805.00M 1625.00M 1428.00M 1925.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SOLV
Solventum Corp.		 -0.20
0.23%		 88.42 10.98 13.30 1.84 3.19 2.43 8.18
ISRG
Intuitive Surgical Inc		 -8.88
1.97%		 440.65 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme		 -2.56
1.26%		 200.18 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -1.98
1.94%		 99.87 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 0.83
0.39%		 215.35 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

Solventum Corp.

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

1750 Yankee Doodle Road, Eagan, MN, United States, 55121

(651) 733-1110

https://www.solventum.com

20584

Name Title Year Born
Mr. Bryan C. Hanson CEO & Director 1967
Mr. Wayde D. McMillan Executive VP & CFO 1970
Ms. Amy Landucci Chief Information & Digital Officer 1975
Ms. Marcela A. Kirberger Chief Corporate & Legal Affairs Officer & Corporate Secretary 1967
Ms. Heather L. Knight Chief Commercial Officer 1972
Mr. Neil C. Zieselman Senior VP, Controller & Chief Accounting Officer 1976
Ms. Amy Wakeham Senior Vice President of Investor Relations & External Finance Communications NA
Ms. Kate Dobbs Chief Communications & Corporate Marketing Officer NA
Ms. Rachel H. Ellingson Chief Strategy & Corporate Development Officer 1970
Ms. Tammy L. Gomez Chief Human Resources Officer 1973

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…